Uzbekistan Recalls Certain Batches of “Telsartan N” Due to Manufacturing Defect

Tashkent, Uzbekistan (UzDaily.com) — Uzbekistan has initiated a recall of specific batches of the medication “Telsartan N,” which is used to treat arterial hypertension.

According to the Center for Pharmaceutical Product Control, the manufacturer, Dr. Reddy’s Laboratories, decided to withdraw the drug from pharmacies after detecting a manufacturing defect.

The recall was prompted by laboratory test results for batch C2501976, in which the content of the active ingredient hydrochlorothiazide did not meet established standards. At the same time, batch C2501977 was also withdrawn, as it was produced from the same raw material lot and could potentially have similar quality deviations.

Experts warn that using the drug with an incorrect composition may negatively affect treatment efficacy and blood pressure control. “Telsartan N” is considered a vital medication for patients with hypertension, as it helps dilate blood vessels and reduces the risk of heart attack and stroke.

Deviations in the composition of active ingredients make such therapy unsafe or ineffective.

In this regard, “Uzpharmcontrol” has urged citizens to carefully check any supplies of the medication in their home medicine cabinets.

If the specified batches are found, it is recommended to refrain from using them and consult a healthcare provider for guidance and alternative treatment options.